You are here

  • Home
  • Archive
  • Volume 75, Issue Suppl 2
  • SAT0403 Treatment with Golimumab or Infliximab Reduces Health Resource Utilization and Increases Work Productivity in Patients with Ankylosing Spondylitis in The QUO-VADIS Study, A Large, Prospective Real-Life Cohort

Citation Tools

Article menu
Download PDFPDF
Poster Presentations
Spondyloarthritis - treatment
SAT0403 Treatment with Golimumab or Infliximab Reduces Health Resource Utilization and Increases Work Productivity in Patients with Ankylosing Spondylitis in The QUO-VADIS Study, A Large, Prospective Real-Life Cohort

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Sarzi-Puttini P, Van Den Bosch F, Claudepierre P, et al
SAT0403 Treatment with Golimumab or Infliximab Reduces Health Resource Utilization and Increases Work Productivity in Patients with Ankylosing Spondylitis in The QUO-VADIS Study, A Large, Prospective Real-Life Cohort
Annals of the Rheumatic Diseases 2016;75:815-816.